1. Home
  2. SABS vs EHLD Comparison

SABS vs EHLD Comparison

Compare SABS & EHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • EHLD
  • Stock Information
  • Founded
  • SABS 2014
  • EHLD 2024
  • Country
  • SABS United States
  • EHLD Greece
  • Employees
  • SABS N/A
  • EHLD N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • EHLD
  • Sector
  • SABS Health Care
  • EHLD
  • Exchange
  • SABS Nasdaq
  • EHLD NYSE
  • Market Cap
  • SABS 15.8M
  • EHLD 17.2M
  • IPO Year
  • SABS N/A
  • EHLD N/A
  • Fundamental
  • Price
  • SABS $2.75
  • EHLD $7.65
  • Analyst Decision
  • SABS Strong Buy
  • EHLD
  • Analyst Count
  • SABS 5
  • EHLD 0
  • Target Price
  • SABS $11.80
  • EHLD N/A
  • AVG Volume (30 Days)
  • SABS 37.3K
  • EHLD 56.1K
  • Earning Date
  • SABS 08-07-2025
  • EHLD 08-15-2025
  • Dividend Yield
  • SABS N/A
  • EHLD 7.18%
  • EPS Growth
  • SABS N/A
  • EHLD N/A
  • EPS
  • SABS N/A
  • EHLD 4.74
  • Revenue
  • SABS $377,835.00
  • EHLD $14,687,504.00
  • Revenue This Year
  • SABS N/A
  • EHLD N/A
  • Revenue Next Year
  • SABS N/A
  • EHLD N/A
  • P/E Ratio
  • SABS N/A
  • EHLD $1.60
  • Revenue Growth
  • SABS N/A
  • EHLD N/A
  • 52 Week Low
  • SABS $1.00
  • EHLD $3.83
  • 52 Week High
  • SABS $5.01
  • EHLD $12.80
  • Technical
  • Relative Strength Index (RSI)
  • SABS 75.33
  • EHLD N/A
  • Support Level
  • SABS $2.31
  • EHLD N/A
  • Resistance Level
  • SABS $2.98
  • EHLD N/A
  • Average True Range (ATR)
  • SABS 0.24
  • EHLD 0.00
  • MACD
  • SABS 0.09
  • EHLD 0.00
  • Stochastic Oscillator
  • SABS 89.31
  • EHLD 0.00

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About EHLD EUROHOLDINGS LTD

Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.

Share on Social Networks: